ArticleFrontiers in pharmacology2022

GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS.

Zheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.